Atrial fibrillation burden during the coronavirus disease 2019 pandemic
ConclusionDuring the first 100 days of COVID-19, a 33% increase in AF episodes occurred with a 34% increase in the proportion of patients with AF episodes observed in states with higher COVID-19 prevalence. These findings suggest a possible association between pandemic-associated social disruptions and AF in patients with CIEDs.Clinical TRIAL registrationAustralian New Zealand Clinical Trial Registry: ACTRN12620000692932.
Source: Europace - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Cardiology | Clinical Trials | Coronavirus | COVID-19 | New Zealand Health | Pandemics | Study